Screener
MoonLake Immunotherapeutics MLTX Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from MoonLake Immunotherapeutics’s reported figures.
Based on the most recent quarter.
The source filing: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 8:55 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001821586-26-000007
FAQ
- What is MoonLake Immunotherapeutics's price / book?
- MoonLake Immunotherapeutics (MLTX) reported price / book of 5.3× in Q1 2026.
- How has MoonLake Immunotherapeutics's price / book changed year-over-year?
- MoonLake Immunotherapeutics's price / book decreased by 13.2% year-over-year, from 6.1× to 5.3×.
- What is the long-term trend for MoonLake Immunotherapeutics's price / book?
- Over 3 years (2022 to 2025), MoonLake Immunotherapeutics's price / book has grown at a -28.4% compound annual growth rate (CAGR), from 8.3× to 3.1×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about MoonLake Immunotherapeutics's price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude